Free NewsletterPro Login

Warning: Undefined variable $stocks in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 448

Warning: foreach() argument must be of type array|object, null given in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 448

Warning: Undefined variable $funds in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 472

Warning: foreach() argument must be of type array|object, null given in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 472
/* the link was here */
×
Free investor livestream — Nov 17

How To Use ChatGPT & Claude To Research Stocks Like A Pro

01
The prompt we use to break down any stock
02
How to fact-check what AI tells you
03
How to compare two stocks in minutes

McKesson and CD&R to Acquire Option Care Health in $5.8 Billion Deal

Published Oct 6, 2026
Share:
Summary:
  • McKesson and Clayton, Dubilier & Rice will buy Option Care Health for about $5.8 billion in enterprise value.
  • McKesson plans to put approximately $1.4 billion toward an interest of roughly 49%, CD&R will be the majority owner, and a framework exists for McKesson to later buy CD&R's stake.
  • Option Care shares jumped 33% at Tuesday's open; the $32.05 per-share price is a 37% premium to Monday's close.

The deal and the price

McKesson Corp. and private equity firm Clayton, Dubilier & Rice said they will acquire Option Care Health Inc. at an enterprise value near $5.8 billion. The price tag is $32.05 per share, a 37% premium to Monday's close. After a Financial Times report on the talks hit overnight, Option Care stock popped 33% when trading opened on Tuesday.

McKesson will put in about $1.4 billion for roughly 49% ownership. CD&R will be the controlling shareholder, and the agreement includes a structure that could allow McKesson to purchase CD&R's stake in the future.

Who keeps control and who runs the business

Option Care will keep its existing management team in place, with CD&R holding the majority interest. McKesson, which already runs medical clinics and infusion services, is folding this into a broader push into specialty care.

"The transaction would further expand McKesson's specialty services platform, adding home and outpatient infusion capabilities aligned with its focus on delivering complex therapies in lower-cost community settings," Elizabeth Anderson of Evercore ISI wrote in a client note. "Strategically, while the initial earnings contribution is modest, the transaction broadens McKesson's specialty care footprint and creates an opportunity to increase its ownership over time."

Healthcare consolidation decides what care costs and who delivers it. Market Briefs covers the sector free every weekday.

Why this matters for care delivery and McKesson's targets

Across the US, Option Care stands as the biggest standalone provider of infusion care, treating people in their homes and at community infusion centers; it delivers medications, fluids, and nutrients to address conditions such as cancer and autoimmune diseases, with care offered both in patients' homes and at neighborhood infusion sites. In 2025, it cared for over 315,000 patients.

McKesson Chief Executive Officer Brian Tyler said the deal fits the company's long-term strategy to increase access as demand grows for specialty and rare-disease therapies that require complex infusions. Many patients still receive infusions in hospitals or large medical centers, which can add cost and time. Option Care provides alternatives in lower-cost community sites or at home.

The bigger play for distributors

Drug distributors have been moving into clinic operations to gain greater control over the supply chain and build more vertically integrated models, according to Drug Channels Institute. The economics are favorable as well: service businesses typically yield higher margins than pure drug distribution. McKesson's oncology and multispecialty division has a long-term adjusted operating profit growth goal of 13% to 16%, while the North American pharmaceutical distribution segment is pegged at 5% to 8%.

For your wallet, the signal is simple: as more treatment shifts outside hospitals, the winners in specialty medicine may look a lot more like service operators than pure distributors.

Private equity in home infusion is a trend worth understanding. Join Market Briefs free and follow it.

Disclosure

Recent News

1 2 3 … 133

Get Market Briefs delivered to your inbox every morning for free!

No fluff. No noise. No politics. Just finance news you can read in 5 minutes.

Blogs

November 20, 2026
Anthropic Stock at $1.5 Trillion: Why This IPO Isn't Amazon in 1997

Anthropic has gone public at a valuation of about $1.5 trillion, while Amazon went public in 1997 at around $440 million. Anthropic has about $33 billion in revenue this year and no profit, and investors are paying more than 40 times its sales, against about 3 times for Amazon. Briefs Finance CEO Jaspreet Singh says nobody knows what comes next, and that long-term investors use downturns to buy instead of panic selling.

Read More
November 17, 2026
Is the Stock Market Going to Crash? Why Nvidia and the Fed Have Investors on Edge
  • Tech stocks are selling off because investors don't know who will lead Nvidia, the company that has been funding the AI industry and selling it chips.
  • Inflation has the Federal Reserve planning to raise interest rates, with a hike expected in December, and that puts pressure on homebuyers, private equity and the $40 trillion national debt.
  • Briefs Finance CEO Jaspreet Singh says nobody has a crystal ball, so his rules are to buy when markets are low, hold long term and invest only what you're willing to lose.
Read More
November 16, 2026
The $40 Trillion National Debt: Trump's 4-Part Plan to Make It Feel Smaller
  • The national debt is above $40 trillion, and the Federal Reserve has gone from sending Washington its profits to losing money.
  • President Trump's four-part plan leans on shorter-term debt, stablecoin companies buying Treasuries, a bigger balance sheet and government stakes in private companies.
  • The goal is to outgrow the debt, not pay it off, so Jaspreet Singh points investors to the seven industries where Washington wants growth.
Read More
November 16, 2026
The Fed Is Talking About a Jumbo Interest Rate Hike. It Has No Easy Way Out
  • The Fed makes its next rate decision on December 9 and is now talking about jumbo interest rate hikes of 0.5%, though one in December looks unlikely.
  • Washington will pay a record $1.05 trillion in interest this year on $40 trillion of debt, and that debt resets at higher rates as the Fed hikes.
  • Jaspreet Singh's five moves are to pay down variable-rate debt, earn interest on your savings, know which stocks feel the pressure, look at value and hedge.
Read More
November 16, 2026
Buying on Margin Is at a Record High. Here's the Risk for the Stock Market
  • Margin debt, the money investors borrow to buy stocks, is at a record of around 4.6% of GDP, up from 3.9% in 2021.
  • ETF money has more than tripled in five years to 7% of GDP, while corporate buybacks and 401(k) money sit below their earlier peaks.
  • Margin calls and panic selling can make the next downturn deeper, so Jaspreet Singh keeps buying broad market funds and says most investors should skip margin debt.
Read More
November 16, 2026
Housing Prices Are Falling. Buying a House Still Isn't Cheaper
  • Housing prices have fallen for four straight weeks, but mortgage rates around 7.2% keep the monthly payment about where it was in 2023.
  • Talk of a jumbo Fed rate hike and a plan to sell Fannie Mae and Freddie Mac on the stock market could both push mortgage rates higher.
  • Briefs Finance CEO Jaspreet Singh treats a house as a liability: buy within your budget and let your investments build the wealth.
Read More
November 14, 2026
Nvidia News: Jensen Huang Is Out, and the "Bank" Behind American AI Just Lost Its Founder
  • Jensen Huang is out at Nvidia over affairs with multiple people, and the company he founded has been the bank of American AI, with about $30 billion into OpenAI and $10 billion into Anthropic.
  • A hotter-than-expected inflation report has Fed officials talking about a possible 0.5% hike in December, and gold, silver, and bitcoin fell on the news.
  • President Trump said the US may not need a deal with Iran, keeping oil prices and inflation risk high. Jaspreet Singh breaks down what it all means for AI stocks and your portfolio.
Read More
November 14, 2026
Record Highs, a 57-Year Low in Jobless Claims, and a Stock Market Bubble: Inside the Weirdest Market in History
  • Stocks are booming at the fastest pace in years, jobless claims just hit a 57-year low, and most investors still feel like nobody is hiring.
  • The Fed is protecting the dollar over the economy, oil swings on every Iran headline, and a few AI companies are carrying an S&P 500 where four of five stocks sit in a correction.
  • Jaspreet Singh explains why circular financing between Nvidia, OpenAI, Anthropic, and SpaceX rhymes with 2008's house of cards, and how his three investing pillars handle a stock market bubble.
Read More
November 14, 2026
Is a Recession Coming? The Fed Just Made a U-Turn It Has Only Made Twice in 60 Years
  • The Fed has raised rates, cut them, then raised them again only twice in the last 60 years, and both times the economy fell into a recession and stocks crashed.
  • The same stop-and-go cycle is playing out now, with one big difference: US debt is 125% of GDP today versus about 30% in 1980.
  • In the 1970s gold rose roughly 24x, real estate 157%, stocks lagged, and cash lost half its value. Jaspreet Singh lays out five assets to consider before the next flip.
Read More
November 14, 2026
The 2027 Tax Brackets Are Out: How Some Investors Can Earn $135,300 and Pay $0
  • The IRS 2027 tax plan keeps the same seven rates but widens every bracket and lifts the married-filing-jointly standard deduction to $33,200.
  • The 0% long-term capital gains bracket rises to $102,100, so a household living on $135,300 of investment income could owe $0 in federal income tax.
  • C corporations still pay 21%, small businesses keep the 20% QBI deduction, and the 401(k) limit climbs to $25,500 with an $8,500 catch-up for investors over 50.
Read More
1 2 3 … 33
Share via
Copy link